U.S. flag

An official website of the United States government

Format
Items per page

Send to:

Choose Destination

Links from OMIM

Items: 9

1.

Metachromatic leukodystrophy, mild

MedGen UID:
866284
Concept ID:
C4017847
Finding
2.

Arylsulfatase a pseudodeficiency, intermediate

MedGen UID:
865533
Concept ID:
C4017096
Finding
3.

Arylsulfatase a pseudodeficiency, severe

MedGen UID:
865532
Concept ID:
C4017095
Finding
4.

Metachromatic leukodystrophy, severe

MedGen UID:
865531
Concept ID:
C4017094
Finding
5.

Metachromatic leukodystrophy, late-onset

MedGen UID:
865530
Concept ID:
C4017093
Finding
6.

Arylsulfatase A pseudodeficiency

MedGen UID:
865528
Concept ID:
C4017091
Finding
7.

Metachromatic leukodystrophy, adult type

A subtype of Metachromatic leukodystrophy characterized by progressive psychomotor regression with an insidious onset after the age of 16 years, most often beginning with intellectual and behavioral changes, such as memory deficits or emotional instability. The clinical picture is dominated by gradual cognitive, later also motor, decline, taking a protracted course with periods of waxing and waning. Decerebration and death occur within decades after disease onset. [from ORDO]

MedGen UID:
199625
Concept ID:
C0751279
Disease or Syndrome
8.

Metachromatic leukodystrophy, late infantile form

A subtype of Metachromatic leukodystrophy characterized by rapidly progressive psychomotor regression with an onset before 30 months of age after a period of apparently normal development. Manifestations developing during the course of the disease are impaired feeding and swallowing due to pseudobulbar palsies, seizures, painful spasms, muscle weakness, ataxia, paralysis, dementia, and loss of speech, vision, and hearing, quickly resulting in complete loss of motor and cognitive skills, and decerebration. Death occurs within the first decade of life. [from ORDO]

MedGen UID:
155529
Concept ID:
C0751278
Disease or Syndrome
9.

Metachromatic leukodystrophy, juvenile type

A subtype of Metachromatic leukodystrophy characterized by progressive psychomotor regression with an onset between 30 months and 16 years of age, often beginning with behavioral abnormalities or deterioration of school performance. Further manifestations are ataxia, gait disturbances, reduced deep tendon reflexes, spasticity, seizures, paralysis, dementia, and loss of speech, vision, and hearing, eventually resulting in complete loss of motor and cognitive skills, and decerebration. The rate of deterioration is variable with possible survival up to the third decade of life. [from ORDO]

MedGen UID:
155528
Concept ID:
C0751276
Disease or Syndrome
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...